RxDoctor Payments Data

Timothy Mitzel, DO

Psychiatry · Pittsburgh, PANPI 1285656785

Payments from drug & device makers

$3,623in general payments, 2019–2025

Across 251 payments — averaging $14.43 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$1K
  • Otsuka America Pharmaceutical, Inc.$379
  • Takeda Pharmaceuticals U.S.A., Inc.$370
  • Alkermes, Inc.$366
  • Avanir Pharmaceuticals, Inc.$323
  • Lundbeck LLC$281
  • plus $726 from 14 others

What the payments were for

  • Food & beverage$3,59399%
  • Education$301%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$3,623 in reported general payments places this provider in the 85th percentile of 1,838 psychiatry providers in Pennsylvania.

See all psychiatry providers in Pennsylvania

Medicare billing

Part B allowed, 2024
$47,162
Medicare patients
108
Services billed
434

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
RexultiBrexpiprazole40$55,915
Bupropion XlBupropion Hcl386$11,615
Duloxetine Hcl271$7,527
VyvanseLisdexamfetamine Dimesylate12$6,631
ConcertaMethylphenidate Hcl16$6,354
Vilazodone Hcl35$5,158
Bupropion Hcl SrBupropion Hcl165$4,732
Venlafaxine Hcl ErVenlafaxine Hcl198$3,555
Sertraline Hcl221$3,294
Clonazepam355$3,021
Trazodone Hcl253$2,990
Lorazepam231$2,443
Dextroamphetamine-AmphetamineDextroamphetamine/Amphetamine66$2,368
Quetiapine Fumarate130$2,082
Lamotrigine217$2,002

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Otsuka America Pharmaceutical, Inc.Rexulti$379$55,91540 claims
Takeda Pharmaceuticals U.S.A., Inc.Vyvanse$370$6,63112 claims
Johnson & JohnsonConcerta$18$6,35416 claims
Almatica Pharma LLCSertraline Hcl$16$3,294221 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 1,838 psychiatry providers in Pennsylvania.

Other psychiatry in Pittsburgh

See the full list for Pennsylvania

Where these figures come from

Is this you, or does something look wrong? →